John Bencich Achieve Life Sciences, Inc. (ACHV) insider trading activity

John Bencich is CEO of ACHIEVE LIFE SCIENCES, INC.. Currently has a direct ownership of 100,636 shares of ACHV, which is worth approximately $430,722. The most recent transaction as insider was on Aug 16, 2024, when has been sold 5,000 shares (Common Stock) at a price of $3.67 per share, resulting in proceeds of $18,350. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 101K

5.23% 3M change

50.81% 12M change

Total Value Held $430,722

John Bencich Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 16 2024	BUY Grant, award, or other acquisition	$18,350 $3.67 p/Share	5,000 Added 4.73%	100,636 Common Stock
Apr 19 2024	SELL Payment of exercise price or tax liability	$27,456 $4.51 p/Share	6,088 Reduced 5.98%	95,636 Common Stock
Apr 19 2024	BUY Exercise of conversion of derivative security	-	25,000 Added 19.73%	101,724 Common Stock
Mar 04 2024	BUY Open market or private purchase	$45,800 $4.58 p/Share	10,000 Added 11.53%	76,724 Common Stock
May 30 2023	BUY Open market or private purchase	$27,500 $5.5 p/Share	5,000 Added 6.97%	66,730 Common Stock
Apr 28 2023	SELL Payment of exercise price or tax liability	$15,145 $8.29 p/Share	1,827 Reduced 2.87%	61,730 Common Stock
Apr 28 2023	BUY Exercise of conversion of derivative security	-	7,500 Added 10.55%	63,557 Common Stock
Apr 21 2023	SELL Payment of exercise price or tax liability	$49,803 $6.8 p/Share	7,324 Reduced 11.83%	54,596 Common Stock
Apr 21 2023	BUY Exercise of conversion of derivative security	-	25,000 Added 28.76%	61,920 Common Stock
Nov 18 2022	BUY Open market or private purchase	-	22,000 Added 37.34%	36,920 Common Stock
Aug 16 2022	BUY Grant, award, or other acquisition	$13,368 $4.37 p/Share	3,059 Added 17.01%	14,920 Common Stock
Apr 28 2022	SELL Payment of exercise price or tax liability	$13,575 $7.43 p/Share	1,827 Reduced 13.35%	11,861 Common Stock
Apr 28 2022	BUY Exercise of conversion of derivative security	-	7,500 Added 35.4%	13,688 Common Stock
Aug 17 2021	SELL Payment of exercise price or tax liability	$143 $6.81 p/Share	21 Reduced 0.34%	6,188 Common Stock
Aug 17 2021	BUY Exercise of conversion of derivative security	-	68 Added 1.08%	6,209 Common Stock
May 27 2021	BUY Open market or private purchase	$42,000 $7.0 p/Share	6,000 Added 49.42%	6,141 Common Stock

John Bencich

CEO

Bothell, WA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACHV shares.

Notify only if

Value

Insider Trading

Get notified when an Achieve Life Sciences, Inc. insider buys or sells ACHV shares.

Notify only if

Operation

Value

Type

News

Receive news related to ACHIEVE LIFE SCIENCES, INC.

Track Activities on ACHV

Account